CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 114 filers reported holding CHEMOCENTRYX INC in Q2 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,093,000 | -73.2% | 66,100 | -75.1% | 0.00% | -69.2% |
| Q2 2020 | $15,254,000 | +17.4% | 265,100 | -18.0% | 0.01% | 0.0% |
| Q1 2020 | $12,990,000 | -57.3% | 323,300 | -57.9% | 0.01% | -43.5% |
| Q4 2019 | $30,397,000 | +245.9% | 768,581 | -40.7% | 0.02% | +228.6% |
| Q3 2019 | $8,787,000 | -35.5% | 1,295,979 | -11.6% | 0.01% | -41.7% |
| Q2 2019 | $13,628,000 | -13.4% | 1,465,381 | +29.3% | 0.01% | -14.3% |
| Q1 2019 | $15,741,000 | +63.3% | 1,133,254 | +28.3% | 0.01% | +27.3% |
| Q4 2018 | $9,638,000 | -1.3% | 883,381 | +14.4% | 0.01% | +10.0% |
| Q3 2018 | $9,762,000 | -51.0% | 772,281 | -48.1% | 0.01% | -9.1% |
| Q2 2018 | $19,938,000 | +90.6% | 1,488,762 | +93.5% | 0.01% | 0.0% |
| Q1 2018 | $10,462,000 | +103.6% | 769,281 | -10.9% | 0.01% | +83.3% |
| Q4 2017 | $5,138,000 | -25.3% | 863,581 | -6.8% | 0.01% | -25.0% |
| Q3 2017 | $6,877,000 | +1.6% | 926,881 | +28.2% | 0.01% | -11.1% |
| Q2 2017 | $6,769,000 | +50.8% | 723,151 | +17.3% | 0.01% | +50.0% |
| Q1 2017 | $4,489,000 | +28.9% | 616,581 | +31.0% | 0.01% | 0.0% |
| Q4 2016 | $3,482,000 | +191.1% | 470,581 | +137.7% | 0.01% | +200.0% |
| Q3 2016 | $1,196,000 | +282.1% | 197,981 | +184.1% | 0.00% | +100.0% |
| Q2 2016 | $313,000 | -25.7% | 69,681 | -58.8% | 0.00% | 0.0% |
| Q1 2016 | $421,000 | +17.3% | 169,054 | +281.6% | 0.00% | 0.0% |
| Q4 2015 | $359,000 | +140.9% | 44,300 | +79.4% | 0.00% | – |
| Q3 2015 | $149,000 | -85.8% | 24,700 | -80.6% | 0.00% | -100.0% |
| Q2 2015 | $1,048,000 | +69.9% | 127,377 | +55.9% | 0.00% | +100.0% |
| Q1 2015 | $617,000 | +41.2% | 81,700 | +27.8% | 0.00% | 0.0% |
| Q4 2014 | $437,000 | +42.3% | 63,923 | -6.4% | 0.00% | 0.0% |
| Q3 2014 | $307,000 | -4.4% | 68,300 | +24.4% | 0.00% | 0.0% |
| Q2 2014 | $321,000 | -75.8% | 54,900 | -72.5% | 0.00% | -66.7% |
| Q1 2014 | $1,325,000 | -41.0% | 199,780 | -48.5% | 0.00% | -40.0% |
| Q4 2013 | $2,246,000 | – | 387,880 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |